The ISAR group of trials and numerous scientific publications have addressed the most clinically relevant questions at the time. As a result, trial outcomes have been directly relevant to clinical practice and immediately useful in addressing unmet medical needs.
Late-breaking trials and trial updates
18 May 2017 – From EuroPCR 2017
Consult this session on Late-breaking trials and trial updates at EuroPCR 2017 to find out more about a randomised multicentre trial to evaluate the utilisation of revascularisation or optimal medical therapy for the treatment of coronary CTO (EuroCTO), results from the COMPARE-ACUTE trial, neurological complications after TAVI and Bioresorbable scaffolds vs. metallic stents in routine coronary intervention on the AIDA study.
OCT at follow-up reveals the cause of PCI failure
20 May 2015 – From EuroPCR 2015
Percutaneous revascularisation for complex multivessel disease in stable coronary artery disease
19 May 2015 – From EuroPCR 2015
Consult this session video on percutaneous revascularisation for complex multivessel disease in stable coronary artery disease from EuroPCR 2015.